Literature DB >> 24602084

The Big Society in an age of austerity: threats and opportunities for Health Consumer and Patients' Organizations in England.

Rob Baggott1, Kathryn Jones1.   

Abstract

BACKGROUND AND
OBJECTIVE: Health consumer and patients' organizations (HCPOs) seek to influence policy. But how are they affected by developments in the policy context and political environment?
DESIGN: The article draws on original research into HCPOs in the UK by the authors, including a major survey undertaken in 1999 and interviews with HCPOs and policymakers between 2000 and 2003 as well as a further survey in 2010. It also draws on a review of key government policies on health and the voluntary sector since 1997.
RESULTS: Developments in the political environment and policy context have created both opportunities and threats for HCPOs as they seek to influence policy. These include policies to promote choice and competition in public services; support for a greater role for the voluntary sector and civil society in health and welfare (including the current government's 'Big Society' idea); NHS reorganization; changes to the system of patient and public involvement; and austerity measures. Devolution of powers within the UK with regard to health policy and the rising profile of the EU in health matters have also had implications for HCPOs. DISCUSSION AND
CONCLUSION: This analysis raises key issues for future research in the UK and elsewhere, such as how will HCPOs be able to maintain independence in an increasingly competitive environment? And how will they fare in an era of retrenchment? There are also challenges for HCPOs in relation to maintaining relationships in a new institutional setting characterized by multilevel governance.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Big Society; Health consumer and patients organizations; Patients organizations; voluntary sector

Mesh:

Year:  2014        PMID: 24602084      PMCID: PMC5810728          DOI: 10.1111/hex.12185

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  5 in total

Review 1.  Research in the European Union.

Authors:  Jürgen Sautter; Regina Wick; Franz Adlkofer; Mary G Baker
Journal:  Lancet Neurol       Date:  2003-11       Impact factor: 44.182

2.  Personal healthcare budgets: what can England learn from the Netherlands?

Authors:  Ewout van Ginneken; Peter P Groenewegen; Martin McKee
Journal:  BMJ       Date:  2012-03-06

3.  Devolution and divergence in UK health policies.

Authors:  Scott L Greer
Journal:  BMJ       Date:  2008-12-15

4.  Undermining patient and public engagement and limiting its impact: the consequences of the Health and Social Care Act 2012 on collective patient and public involvement.

Authors:  Jonathan Q Tritter; Meri Koivusalo
Journal:  Health Expect       Date:  2013-06       Impact factor: 3.377

5.  Prevention better than cure? Health consumer and patients' organisations and public health.

Authors:  Rob Baggott; Kathryn L Jones
Journal:  Soc Sci Med       Date:  2011-07-08       Impact factor: 4.634

  5 in total
  4 in total

1.  Representing Whom? U.K. Health Consumer and Patients' Organizations in the Policy Process.

Authors:  Rob Baggott; Kathryn L Jones
Journal:  J Bioeth Inq       Date:  2018-05-25       Impact factor: 1.352

2.  Challenges Facing Healthwatch, a New Consumer Champion in England.

Authors:  Pam Carter; Graham Martin
Journal:  Int J Health Policy Manag       Date:  2016-01-21

3.  Legislating Patient Representation: A Comparison Between Austrian and German Regulations on Self-Help Organizations as Patient Representatives.

Authors:  Daniela Rojatz; Julia Fischer; Hester Van de Bovenkamp
Journal:  J Bioeth Inq       Date:  2018-07-02       Impact factor: 1.352

4.  Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016).

Authors:  Piotr Ozieranski; Marcell Csanádi; Emily Rickard; Shai Mulinari
Journal:  BMJ Open       Date:  2020-09-19       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.